Fixed combination of nivolumab and relatlimab in the treatment of metastatic melanoma: managing musculoskeletal toxicity without stopping therapy
Abstract
Fixn kombinace nivolumabu s relatlimabem prokazuje vy innost ne monoterapie nivolumabem a souasn m podobnou innost, ale vrazn pznivj bezpenostn profil ne kombinace nivolumabu s ipilimumabem. Demonstrovan pacient s metastazujcm melanomem ml po lb nivolumabem s relatlimabem vraznou regresi metastz a hlavnm nedoucm inkem byly artralgie zvanosti stupn 2-3. Dky vasnmu zahjen kortikoterapie dolo k rychlmu stupu pot a mohl v imunoterapii bezpen pokraovat.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Cutaneous Melanoma Detection and Management
Chemotherapy-related skin toxicity
Publication details
- Journal / source
- Onkologie
- Volume
- 20
- Issue
- 1
- Pages
- 16–19
- Publication date
- 16 March 2026